Grown Rogue International (GRUSF) Total Non-Current Liabilities (2009 - 2026)

Grown Rogue International (GRUSF) recorded quarterly Total Non-Current Liabilities of $2.9 million in Q1 2026, down 3.0% quarter-over-quarter from $3.0 million in Q4 2025, and down 100.0% on a YoY basis from $28185405389.2 billion in Q1 2025.

Grown Rogue International (GRUSF) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends

Grown Rogue International's Total Non-Current Liabilities history runs 17 years deep, the most recent figure standing at $2.9 million for Q1 2026.

  • In Q1 2026, Total Non-Current Liabilities fell 100.0% year-over-year to $2.9 million; the TTM figure through Mar 2026 stood at $2.9 million (down 100.0% YoY), while the FY2025 annual figure was $3.0 million, down 5.41% from the prior year.
  • Total Non-Current Liabilities was $2.9 million for Q1 2026 at Grown Rogue International, down from $3.0 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $28159893000.0 billion in Q1 2025 to a low of -$4.9 million in Q4 2023.
  • Historically, Total Non-Current Liabilities has averaged $5260453667.2 billion across 5 years, with a median of $3.0 million in 2025.
  • The sharpest annual moves came in 2023 and 2025: Total Non-Current Liabilities plunged 780.32% in 2023, then surged 1652.92% in 2025.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $715461.0 in 2022, then surged by 894.27% to $7.1 million in 2023, then plunged by 102.72% to -$193195.5 in 2024, then soared by 1652.92% to $3.0 million in 2025, then retreated by 3.0% to $2.9 million in 2026.
  • The last three Total Non-Current Liabilities figures came in at $2.9 million (Q1 2026), $3.0 million (Q4 2025), and $23005.2 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 18.28 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 11.64 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 599.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 44.12 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 1.24 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 6.26 Bn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 2.44 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 1.81 Bn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 1.13 Bn
10 Grown Rogue International - - 3.96 Mn 2.91 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.91 Mn
Dec 31, 2025 3.00 Mn
Sep 30, 2025 23,005.21 Bn
Jun 30, 2025 19,184,167,000.00 Bn
Mar 31, 2025 28,159,893,000.00 Bn
Dec 31, 2024 -193,195.51
Dec 31, 2023 7.11 Mn
Oct 31, 2023 -4.87 Mn
Oct 31, 2022 715,461.00
Oct 31, 2021 1.23 Mn
Oct 31, 2020 68,994.00
May 31, 2018 -583,997.90
Feb 28, 2018 -595,244.05
Nov 30, 2017 -597,802.38
Aug 31, 2017 -170,845.96
May 31, 2017 -1.07 Mn
Feb 28, 2017 20.75 Mn
Nov 30, 2016 20.72 Mn
Aug 31, 2016 -1.35 Mn
May 31, 2016 -25.54 Mn